Contact
QR code for the current URL

Story Box-ID: 1200268

Hemovent GmbH Pascalstr. 59 52076 Aachen, Germany http://hemovent.com
Contact Ms Sandra Bastian +49 241 99013327
Company logo of Hemovent GmbH

Hemovent’s MOBYO® Gas Exchanger Receives MDR Certification and 28-Day Approval

Two successes at one time: The MOBYO® gas exchanger from Hemovent received MDR certification. At the same time, the previously authorized use of the MOBYO® has been extended to 28 days.

(PresseBox) (Aachen, Germany, )
After Hemovent’s MOBYBOX® ECLS system received Medical Device Regulation (MDR 2017/745) certification last year, the MOBYO® gas exchanger is following suit and has also successfully received MDR certification. In addition, the MOBYO® gas exchanger is now approved for 28-day use. This means that all the products Hemovent manufactures itself received MDR certification within one year.

“I am repeatedly impressed at everything our team manages to achieve in such a short time. The 28-day authorization of the MOBYO® gas exchanger in particular will provide safer patient treatment for our users,” said Dr. Jürgen O. Böhm, CEO & CMO of Hemovent GmbH.

The MOBYO® gas exchanger is part of the MOBYBOX® ECLS system and is also naturally available separately. The innovative design of the MOBYO® ensures extremely low pressure reduction while providing highly efficient gas exchange; the creatively designed cylindrical membrane stacks prevent stagnation areas. This permits gentle blood flow behavior, resulting in greater safety and reliability in patient treatment. The MDR certification for the MOBYO® and the 28-day authorization are further significant steps for the company as it internationalizes its ECLS products.

Attachments

Website Promotion

Website Promotion

Hemovent GmbH

Hemovent is an emerging medical device company based in Aachen, Germany that has won multiple awards. Its MOBYBOX® product is an extremely portable machine that easily fits in a backpack and is even easier to operate. With this highly innovative ECLS system, Hemovent wants to expand the application area of this life-saving technology for heart-lung support to a fully new dimension. Since 2021, Hemovent has been focusing on growth and aims to shape the future of the portable ECLS system market in intensive care medicine over the long term as a member of MicroPort®, a global medical devices company operating in multiple international markets.

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.